because it is not a pharmacy medicine YET
The final decision by the delegate to make Astodrimer sodium nasal spray schedule 2 is sometime after today when final submissions close. A chance for us to say we support the interim decision and then he/she considers final submissions. In the interim decision 1 June was mentioned for potential pharmacy. SPL is not going to excite the market about interim decisions but I hope they have commenced Australian Therapeutic Goods Register ATGR application for Viraleze and with final decision the market notification is made
Why no SPL announcement on TGA decison, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65751 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 226460 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |